RECRUITING

Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

Official Title

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Female Adults with Prediabetes.

Quick Facts

Study Start:2024-09-20

Study Completion:2025-06-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06735651

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 65 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Women aged 45-65 years old. * Prediabetes (fasting blood glucose 100-125 mg/dL and/or HbA1c percentage between 5.7-6.4). * Body Mass Index between 25-30 kg/m\^2.	* Allergies to berries. * Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs. * Active cancer, gastrointestinal, renal, thyroid, stage 1 \& 2 hypertension, and other cardiovascular diseases, neurological diseases, or severe head injury. * Smoking. * Consumes greater than 2 alcoholic beverages per day. * Consumes antioxidant, probiotic, and prebiotic supplements. * Pregnant or Lactating * Actively participating in a weight loss program * Currently taking berry supplements or recently participated in another study taking berry supplements.

Inclusion Criteria

Exclusion Criteria

* Women aged 45-65 years old.
* Prediabetes (fasting blood glucose 100-125 mg/dL and/or HbA1c percentage between 5.7-6.4).
* Body Mass Index between 25-30 kg/m\^2.

* Allergies to berries.
* Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs.
* Active cancer, gastrointestinal, renal, thyroid, stage 1 \& 2 hypertension, and other cardiovascular diseases, neurological diseases, or severe head injury.
* Smoking.
* Consumes greater than 2 alcoholic beverages per day.
* Consumes antioxidant, probiotic, and prebiotic supplements.
* Pregnant or Lactating
* Actively participating in a weight loss program
* Currently taking berry supplements or recently participated in another study taking berry supplements.

Contacts and Locations

Study Contact

Rafaela G Feresin, PhD

CONTACT

404-413-1233

rferesin@gsu.edu

Principal Investigator

Rafaela G Feresin, PhD

PRINCIPAL_INVESTIGATOR

Georgia State University

Study Locations (Sites)

Georgia State University

Atlanta, Georgia, 30303

United States

Collaborators and Investigators

Sponsor: Georgia State University

Rafaela G Feresin, PhD, PRINCIPAL_INVESTIGATOR, Georgia State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-20

Study Completion Date2025-06-01

Study Record Updates